You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Letters Hospital Mortality Risk Adjustment Using Claims Data—Reply
Michael Pine; Harmon S. Jordan; Anne Elixhauser; Donald E. Fry; David C. Hoaglin
JAMA 2007; 297: 1984.
[Extract][Full text][PDF]
Original Contributions Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
Paul Erne; Andreas W. Schoenenberger; Dieter Burckhardt; Michel Zuber; Wolfgang Kiowski; Peter T. Buser; Paul Dubach; Therese J. Resink; Matthias Pfisterer
JAMA 2007; 297: 1985-1991.
[Abstract][Full text][PDF]
Original Contributions Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
Nirat Beohar; Charles J. Davidson; Kevin E. Kip; Lynne Goodreau; Helen Aslanidou Vlachos; Sheridan N. Meyers; Keith H. Benzuly; James D. Flaherty; Mark J. Ricciardi; Charles L. Bennett; David O. Williams
JAMA 2007; 297: 1992-2000.
[Abstract][Full text][PDF][ JAMA News Video ]
Original Contributions Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
Htut K. Win; Angel E. Caldera; Kelly Maresh; John Lopez; Charanjit S. Rihal; Manish A. Parikh; Juan F. Granada; Sachin Marulkar; Deborah Nassif; David J. Cohen; Neal S. Kleiman; for the EVENT Registry Investigators
JAMA 2007; 297: 2001-2009.
[Abstract][Full text][PDF]
Letters Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation
